In the United States, there is a boxed warning of the possible risk, and those with personal or family histories of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 are therefore advised to avoid liraglutide, dulaglutide, exenatide extended release, and semaglutide
For those focused specifically on abdominal fat, the peptides for belly fat resource and the best peptide for visceral fat loss guide provide additional context on how GLP-1 and GIP agonists target different fat depots
TripleHormone-Receptor Agonist Retatrutide for Obesity
It may take some time to adjust to the medication and start feeling the effects
Continue sipping water throughout the morning, targeting 30-40 ounces by noon
Vials should be swirled gently rather than shaken